Profile
AVGR ISRG BDX ALC RMD WST
Company Name Avinger, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. West Pharmaceutical Services, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $2.55M $175.06B $70.07B $48.19B $36.00B $22.75B
Employees 0.07K 13.68K 70.00K 25.00K 9.98K 10.60K
CEO Mr. Jeffrey M. Soinski Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM Mr. Eric M. Green
Ratings
AVGR ISRG BDX ALC RMD WST
Quant Rating Score 2 3 3 3 3 3
Quant Rating Sell Neutral Neutral Neutral Neutral Neutral
Trading
AVGR ISRG BDX ALC RMD WST
Last Close $1.11 $492.63 $242.41 $97.68 $245.02 $313.63
High 52 $13.5 $492.63 $278.46 $97.68 $245.02 $413
Low 52 $0.36 $258.49 $221.47 $69.56 $134.65 $277.16
Price vs. 52 Week High -91.78 % 0 % -12.95 % 0 % 0 % -24.06 %
Price vs. 52 Week Low 208.33 % 90.58 % 9.46 % 40.43 % 81.97 % 13.16 %
Total Return
AVGR ISRG BDX ALC RMD WST
1 Month Return -20.14 % 9.25 % 2.71 % 4.11 % 14.2 % 3.74 %
3 Month Return -48.25 % 22.51 % 4.5 % 9.59 % 18.75 % -5.36 %
6 Month Return -70.4 % 23.81 % 3.02 % 12.61 % 40.32 % -12.57 %
9 Month Return -61.46 % 56.29 % 1.75 % 28.8 % 53.48 % -10.85 %
YTD Return -59.04 % 46.03 % -0.58 % 25.04 % 42.44 % -10.93 %
1 Year Return 134.18 % 58.7 % -12.95 % 18.39 % 53.92 % -23.07 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AVGR ISRG BDX ALC RMD WST
Dividend Yield Percentage (TTM) - - 1.55 % 0.27 % 0.8 % 0.26 %
Dividend Paid and Capex Coverage Ration (TTM) -208.51 % 1.16 % 2.18 % 2.05 % 3.53 % 1.66 %
Dividend Per Share (TTM) - - 3.76 % 0.26 % 1.97 % 0.8 %
Payout Ratio (TTM) -0.38 % - 77.14 % 12.09 % 27.65 % 11.07 %
Growth
AVGR ISRG BDX ALC RMD WST
Asset Growth -43.09 % 19.02 % -0.29 % 1.35 % 1.79 % 5.88 %
Gross Profit Growth -24.53 % 12.71 % -3.62 % 18.11 % 10.75 % -0.62 %
Revenue Growth -7.51 % 14.49 % 2.66 % 15.77 % 10.95 % 2.18 %
Revenue 3 Year -81.76 % 63.36 % 10.28 % 46.5 % 44.86 % 36.66 %
Revenue 5 Year -99.56 % 85.79 % 9.38 % 39.86 % 74.97 % 70.83 %
Revenue 10 Year -99.99 % 223.26 % 63.97 % 53.48 % 189.94 % 101.93 %
EBIT Growth -4.25 % 45.86 % -7.49 % 87.58 % 22.29 % -7.9 %
Net Income Growth -5.12 % 35.98 % -16.58 % 190.75 % 13.75 % 1.28 %
Net Income 3 Yeari Growth Per Share 80.7 % 69.43 % 65.46 % 281.94 % 112.66 % 70.48 %
Net Income 5 Yeari Growth Per Share 99.7 % 54.83 % 330.62 % 525.33 % 145.63 % 185.26 %
Net Income 10 Yeari Growth Per Share 100 % 175.41 % -21.76 % 225.89 % 184.54 % 394.98 %
Operating Income Growth -4.25 % 45.86 % -7.49 % 87.58 % 22.29 % -7.9 %
Operating Cash Flow Growth (CFG) 13.89 % 21.67 % 13.52 % 21.73 % 102.11 % 7.25 %
Operating 3 Year CFG 79.69 % 22.09 % -17.7 % 78.55 % 87.99 % 63.45 %
Operating 5 Year CFG 99.65 % 50.62 % -5.85 % 28.82 % 197.13 % 167.61 %
Operating 10 Year CFG 100 % 111.85 % 35.21 % 11.44 % 244.62 % 229.88 %
EPS Growth 44.27 % 37.63 % -16.19 % 201.43 % 13.4 % 1.4 %
EPS Diluted Growth 44.27 % 37.81 % -15.99 % 198.57 % 13.63 % 1.94 %
Book Value Per Share -179.29 % 21.29 % 1.5 % 4.44 % 17.57 % 7.45 %
Share Holder 3 Year Equity Growth Per Share -109.9 % 36.28 % 5.73 % 8.65 % 66.6 % 54.52 %
Share Holder 5 Year Equity Growth Per Share -100.3 % 93.27 % 10.89 % -9.73 % 128.49 % 105.22 %
Share Holder 10 Year Equity Growth Per Share 100 % 290.63 % 248.77 % -13.54 % 166.2 % 197.74 %
Dividend Per Share Growth -100 % - 2.5 % 19.49 % 9.12 % 5.5 %
Dividend 3 Year Growth Per Share -100 % - 5.8 % - 23.08 % 17.87 %
Dividend 5 Year Growth Per Share -100 % - 8.45 % - 29.8 % 34.66 %
Dividend 10 Year Growth Per Share - - 96.74 % - 91.97 % 99.23 %
Debt Growth -5.89 % -4.26 % -1.16 % 1.48 % -44.68 % -2.8 %
Free Cash Flow Growth 14.1 % -21.79 % 27.41 % 21.44 % 130 % -5.67 %
Updated On 31 Dec 2023 31 Dec 2023 30 Sep 2023 31 Dec 2023 30 Jun 2024 31 Dec 2023
Profitability
AVGR ISRG BDX ALC RMD WST
Gross Profit Margin TTM 19.96 % 66.86 % 42.06 % 55.29 % 57.92 % 35.73 %
Return on Assets TTM -97.96 % 12.57 % 2.54 % 3.71 % 14.86 % 15.04 %
Return on Equity TTM 1757.12 % 15.36 % 5.51 % 5.34 % 22.41 % 19.08 %
Return on Capital Employed TTM -215.41 % 12.88 % 4.77 % 5.27 % 22.14 % 20.72 %
Net Income Per EBT TTM 87.43 % 93.85 % 84.46 % 106.81 % 80.72 % 85.87 %
EBT Per Ebit TTM 108.48 % 114.25 % 71.56 % 71.49 % 95.83 % 103.3 %
EBIT Per Revenue TTM -240.46 % 25.79 % 11.79 % 14.76 % 29.03 % 20.57 %
Cash Flow To Debt Ratio TTM -264.48 % 1671.71 % 20.42 % 39.25 % 191.3 % 331.45 %
Receivables Turnover TTM 7.98 6.09 7.64 4.74 5.19 5.73
Payables Turnover TTM 8.2 12.91 2.31 5.04 8.05 8.73
Inventory Turnover TTM 1.44 1.81 3.53 1.88 2.33 4.41
Fixed Asset Turnover TTM 342.98 % 183.94 % 304.2 % 208.76 % 650.22 % 175.95 %
Asset Turnover TTM 42.95 % 45.48 % 35.67 % 32.92 % 66.15 % 82.44 %
Operating Cash Flow Per Share TTM -9.32 4.05 13.62 3.77 9.54 10.31
Free Cash Flow Per Share TTM -9.32 0.54 11.13 2.2 8.76 4.89
Cash Per Share TTM 538.92 % 1340.06 % 1843.47 % 277.32 % 170.43 % 611.23 %
Operating Cash Flow Sales Ratio TTM -204.89 % 18.96 % 19.9 % 19.09 % 30.82 % 26.15 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.05 % 13.43 % 81.67 % 58.41 % 91.8 % 47.46 %
Cash Flow Coverage Ratios TTM -264.48 % 1671.71 % 20.42 % 39.25 % 191.3 % 331.45 %
Price To Free Cash Flows Ratio TTM -0.17 907.51 21.75 44.19 27.99 63.71
Price To Operating Cash Flows Ratio TTM -0.12 121.79 17.79 25.88 25.69 30.43
Price Cash Flow Ratio TTM -0.12 121.79 17.79 25.88 25.69 30.43
Income Statement (TTM)
AVGR ISRG BDX ALC RMD WST
Revenue $0.01B $7.12B $19.37B $10.09B $4.69B $2.95B
Gross Profit $0B $4.73B $8.17B $5.61B $2.61B $1.13B
Gross Profit Ratio 26.18% 66.39% 42.17% 55.57% 55.68% 38.28%
EBITDA $-0.02B $2.19B $4.72B $2.56B $1.6B $0.88B
Net Income $-0.02B $1.8B $1.48B $0.97B $1.02B $0.59B
EPS Diluted -23.31 5.03 4.94 2.09 6.92 7.88
Balance Sheet (MRQ)
AVGR ISRG BDX ALC RMD WST
Long Term Debt $0B $-0.08B $14.74B $4.59B $0.7B $0.16B
Total Liabilities $0.02B $2.04B $26.98B $8.99B $2.01B $0.95B
Total Equity $-0.01B $13.4B $25.8B $20.62B $4.86B $2.88B
Total Investments $0B $4.59B $0.01B $0.28B $0.17B $0.21B
Total Debt $0.02B $0.09B $15.88B $5.14B $0.87B $0.31B
Total Assets $0.01B $15.44B $52.78B $29.6B $6.87B $3.83B
Cash Flow Statement (TTM)
AVGR ISRG BDX ALC RMD WST
Net Income $-0.02B $1.82B $1.53B $1.04B $1.02B $0.59B
Inventory $-0B $-0.71B $-0.02B $-0.29B $0.17B $-0.01B
Dividends Paid $0B $0B $-1.11B $-0.12B $-0.28B $-0.06B
Operating Cash Flow $-0.01B $1.81B $2.99B $1.48B $1.4B $0.78B
Capital Expenditure $-0B $-1.06B $-0.87B $-0.91B $-0.11B $-0.36B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 2.55
ALC Alcon Inc. 97.68
ANGO AngioDynamics, Inc. 7.46
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 153.19
ATRC AtriCure, Inc. 26.21
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AZTA Azenta, Inc. 49.52
BAX Baxter International Inc. 37.94
BDX Becton, Dickinson and Company 242.41
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 16.43
BLFS BioLife Solutions, Inc. 25.88
COO The Cooper Companies, Inc. 105.73
DXR Daxor Corporation 8.4499
EKSO Ekso Bionics Holdings, Inc. 1.2
FEMY Femasys Inc. 1.17
GCTK GlucoTrack, Inc. 2.5992
GMVD G Medical Innovations Holdings Ltd 0.1835
ETFs With Exposure to AVGR
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 179.52
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 136.29
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 136.3
VEMPX Vanguard Extended Market Index InstlPlus 0 336.35
Unlock